Lillis, Rebecca
Kuritzky, Louis
Huynh, Zune
Arcenas, Rodney
Hansra, Avneet
Shah, Roma
Yang, Baiyu
Taylor, Stephanie N.
Funding for this research was provided by:
Roche Molecular Systems
Article History
Received: 13 November 2022
Accepted: 29 June 2023
First Online: 13 July 2023
Declarations
:
: All data were compliant with the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Research performed in accordance with the Declaration of Helsinki. Institutional review board approval was not required. There is no identifiable information from individuals within these data sets. Consent to participate not applicable.
: Not applicable.
: ZH, RA, AH, RS and BY are employees of Roche Molecular Systems and report receiving stocks and stock options from Roche. RL reports receiving funding for this study from Roche, receipt of previous grants for clinical trials from Hologic, Visby, OrthoClinical Diagnostics, Becton Dickinson, Cepheid, Merck and Gilead, as well as previous speakers’ bureau payment and support for meeting attendance from Cepheid and reports participation in a Roche advisory board. SNT reports receiving funding for this study from Roche Molecular Systems, as well as receipt of previous grants from Roche Molecular Systems paid directly to their institution. LK reports receiving consulting fees for this study from Roche Diagnostics, as well as receipt of previous consulting fees and medical writing support from Roche Diagnostics.